The Impact of Medication Reconciliation on Discrepancies and All-cause Readmission Among Hospitalized Patients With Chronic Kidney Disease: A Quasi-experimental Study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 323
- 试验地点
- 1
- 主要终点
- all-cause 90-day readmission
研究概览
简要总结
This study aimed to evaluate the impact of combining medication reconciliation with medication review on reducing medication discrepancies at discharge and all-cause readmissions among CKD patients, in comparison to a retrospective control group that received usual care, which may or may not have included medication reconciliation.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Sequential
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 100 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult (18 years or older) admitted patients with CKD (stages 2-5 ), who were using at least three chronic medicines at home, and were hospitalized for at least 48 hours.
排除标准
- •Patients with kidney transplantation .
- •Patients who have difficulties in responding to interviews and did not have family member or caregiver on behave.
- •Patients who refused to provide a written informed consent.
研究组 & 干预措施
Retrospective control group in which patients received the usual care
A retrospective control group in which patients received the usual care that may or may not include medication reconciliation
Intervention group
interventional group, in which patients received a supplemented medication reconciliation service.
干预措施: Medication reconciliation service (Other)
结局指标
主要结局
all-cause 90-day readmission
时间窗: 90 days after discharge
The primary outcome in this study was the likelihood of all-cause 90-day readmission as extracted from medical records for both study groups
次要结局
未报告次要终点